
About Lingfu Biotechnology
Lingfu Biotechnology is a Healthcare company based in Beijing (China) founded in 2021. Lingfu Biotechnology has raised $30.76 million across 1 funding round from investors including China Life Private Equity, Legend Capital and Puhua Capital. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Animal Models.
Company details
Animal research service provider that offers animal behavior analysis services. It offers industry chain of experimental animals which includes beagle dogs, marmosets, cynomolgus monkeys and miniature pigs for research institutions, hospitals and others.
- Headquarters Beijing, China
- SectorsHealthcare
- Total Equity Funding$30.76M (USD)
in 1 rounds
- Latest Funding Round$30.76M (USD), Seed
Apr 2022
- InvestorsChina Life Private Equity
& 3 more
Funding Insights of Lingfu Biotechnology
Lingfu Biotechnology has successfully raised a total of $30.76M through 1 strategic funding round. The most recent funding activity was a Seed round of $30.76 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $30.76M
- Total Rounds 1
- Last Round Seed β $30.76M
- First Round $30.76M
(Apr 2022)
- Investors Count 4
All 1 funding rounds of Lingfu Biotechnology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2022 | $30.76M | Seed | β | China Life Insurance |
4 investors in total: 4 institutional.
Investors in Lingfu Biotechnology
Lingfu Biotechnology has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include China Life Private Equity, Legend Capital and Puhua Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are managed from bases in China. | chinalifepe.com | Chaoyang, China | ||
Venture Capital firm focused on multiple sectors | legendcapital.com.cn | Haidian, China | ||
Health and technology startups are invested in by Puhua Capital. | puhuacapital.com | Hangzhou, China | ||
| changdevelopmentcapital.tcc.mode |
Investor details for Lingfu Biotechnology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Lingfu Biotechnology
2 dated milestones of Lingfu Biotechnology across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Lingfu Biotechnology is founded.
- Funding First funding round of $30.8M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lingfu Biotechnology
Lingfu Biotechnology was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Lingfu Biotechnology is headquartered in Beijing, China.
Lingfu Biotechnology is a funded company, having raised a total of $30.76M across 1 funding round to date. The company's 1st funding round was a Seed of $30.76M, raised on Apr 2022.
Animal research service provider that offers animal behavior analysis services. It offers industry chain of experimental animals which includes beagle dogs, marmosets, cynomolgus monkeys and miniature pigs for research institutions, hospitals and others.
Lingfu Biotechnology has 4 investors. Key investors include China Life Private Equity, Legend Capital, Puhua Capital, and Chang Development Capital.